5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin

European Journal of Pharmacology

Volumn 352, Issue 2-3, 1998, Pages 143-149

  Rudd, John A ^a   Ngan, Man P ^a   Wai, Man K ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

5 HT3 receptor; Conditioned taste aversion; Rat

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; CISPLATIN; EMETIC AGENT; IPECAC; SEROTONIN; SEROTONIN 3 RECEPTOR; ANTINEOPLASTIC AGENT; GRANISETRON; ONDANSETRON; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TASTE AVERSION; ANIMAL; AVOIDANCE BEHAVIOR; CONDITIONED REFLEX; DRINKING BEHAVIOR; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TASTE;

ANIMALS; ANTINEOPLASTIC AGENTS; AVOIDANCE LEARNING; CISPLATIN; CONDITIONING, CLASSICAL; DRINKING BEHAVIOR; GRANISETRON; IPECAC; MALE; ONDANSETRON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN; SEROTONIN ANTAGONISTS; TASTE;

EID: 0031594881     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00359-8     Document Type: Article

References (38)

1. Andrews, P.L.R., Rapeport, W.G., Sanger, G.J., 1988. Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol. Sci. 9, 334-341.
2. Bhargava, K.P., Gupta, P.C., Chandra, O., 1961. Effect of ablation of the chemoreceptor trigger zone (CT zone) on the emetic response to intraventricular injections of apomorphine and emetine in the dog. J. Pharmacol. Exp. Ther. 134, 329-331.
3. Borison, H.L., Wang, S.C., 1953. Physiology and pharmacology of vomiting. Pharmacol. Rev. 5, 193-230.
4. Butcher, M.E., 1993. Global experience with ondansetron and future potential. Oncology 50, 191-197.
5. 3 receptors. Br. J. Pharmacol. 94, 397-412.
6. Costall, B., Domeney, A.M., Naylor, R.J., Owera-Atepo, J.B., Rudd, J.A., Tattersall, F.D., 1990. Fluphenazine, ICS 205-930 and DL-fenfluramine differentially antagonize drug-induced emesis in the ferret. Neuropharmacology 29, 453-462.
7. Fox, R.A., 1992. Current status: animal models of nausea. In: Bianchi, A.L., Grélot, L., Miller, A.D., King, G.L. (Eds.), Mechanisms and Control of Emesis, Vol. 223. John Libbey Eurotext, Paris, pp. 341-278.
8. Fox, R.A., Corcoran, M., Brizzee, K.R., 1990. Conditioned taste aversion and motion sickness in cats and squirrel monkeys. Can. J. Physiol. Pharmacol. 68, 269-278.
9. Gralla, R.J., Rittenberg, C., Peralta, M., Lettow, L., Cronin, M., 1996. Cisplatin and emesis: aspects of treatment and a new trial for delayed emesis using oral dexamethasone plus ondansetron beginning at 16 h after cisplatin. Oncology 53 (Suppl. 1), 86-91.
10. Grant, V.L., 1987. Do conditioned taste aversions result from activation of emetic mechanisms?. Psychopharmacology (Berl.) 93, 405-415.
11. 3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br. J. Pharmacol. 97, 247-255.
12. Houpt, T.A., Philopena, J.M., Wessel, T.C., Joh, T.H., Smith, G.P., 1994. Increased c-fos expression in nucleus of the solitary tract correlated with conditioned taste aversion to sucrose in rats. Neurosci. Lett. 172, 1-5.
13. Kamato, T., Ito, H., Nagakura, Y., Nishida, A., Yuki, H., Yamano, M., Miyata, K., 1993. Mechanisms of cisplatin- and m-chlorophenylbi-guanide-induced emesis in ferrets. Eur. J. Pharmacol. 238, 369-376.
14. 3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur. J. Pharmacol. 159, 157-164.
15. 3 receptor agonist. Eur. J. Pharmacol. 182, 193-197.
16. Kris, M.G., Tyson, L.B., Clark, R.A., Gralla, R.J., 1992. Oral ondansetron for the control of delayed emesis after cisplatin: report of a phase II study and a review of completed trials to manage delayed emesis. Cancer 70, 1012-1016.
17. Leslie, R.A., Reynolds, D.J.M., 1992. Functional anatomy of the emetic circuitry in the brainstem. In: Bianchi, A.L., Grélot, L., Miller, A.D., King, G.L. (Eds.), Mechanisms and Control of Emesis, Vol. 223. John Libbey Eurotext, Paris, pp. 19-27.
18. Martin, M., 1996. The severity and pattern of emesis following different cytotoxic agents. Oncology 53 (Suppl. 1), 226-236.
19. Mele, P.C., McDonough, J.R., McLean, D.B., O'Halloran, K.P., 1992. Cisplatin-induced conditioned taste aversion: attenuation by dexamethasone but not zacopride or GR38032F. Eur. J. Pharmacol. 218, 229-236.
20. Miller, A.D., Nonaka, S., 1992. Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion. J. Pharmacol. Exp. Ther. 260, 509-517.
21. 3-receptor antagonists. Br. J. Clin. Pharmacol. 37, 525-530.
22. Morrow, G.R., Hickok, J.T., Rosenthal, S.N., 1995. Progress in reducing nausea and emesis: comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). Cancer 76, 343-357.
23. Naylor, R.J., Rudd, J.A., 1996. Mechanisms of chemotherapy/ radiotherapy-induced emesis in animal models. Oncology 53 (Suppl. 1), 8-17.
24. Ossenkopp, K.P., Giugno, L., 1990. Nicotine-induced conditioned taste aversions are enhanced in rats with lesions of the area postrema. Pharmacol. Biochem. Behav. 36, 625-630.
25. Rabin, B.M., Hunt, W.A., 1992. Relationship between vomiting and taste aversion learning in the ferret: studies with ionizing radiation, lithium chloride, and amphetamine. Behav. Neural Biol. 58, 83-93.
26. Rudd, J.A., Naylor, R.J., 1996. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret. Br. J. Pharmacol. 118, 209-214.
27. Rudd, J.A., Naylor, R.J., 1997. The actions of ondansetron and dexamethasone to antagonize cisplatin-induced emesis in the ferret. Eur. J. Pharmacol. 322, 79-82.
28. Rudd, J.A., Jordan, C.C., Naylor, R.J., 1994. Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis. Eur. J. Pharmacol. 262, R1-R2.
29. Rudd, J.A., Bunce, K.T., Naylor, R.J., 1996. The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret. Neuropharmacology 35, 91-96.
30. 3 receptor antagonism by BRL 43694 (granisetron). Eur. J. Pharmacol. 159, 113-124.
31. Saxena, P.R., Villalón, C.M., 1990. Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol. 15, S17-S34, Suppl. 7.
32. Smith, W.L., Alphin, R.S., Jackson, C.B., Sancilio, L.F., 1989. The anti-emetic profile of zacopride. J. Pharm. Pharmacol. 41, 101-105.
33. 3-receptor antagonist, GR38032F. Cancer Treat. Rev. 14, 333-336.
34. Sutton, R.L., Fox, R.A., Daunton, N.G., 1988. Role of the area postrema in three putative measures of motion sickness in the rat. Behav. Neural. Biol. 50, 133-152.
35. Torii, Y., Saito, H., Matsuki, N., 1991. 5-Hydroxytryptamine is emetogenic in the house musk shrew, Suncus murinus. Naunyn-Schmiedeberg's Arch. Pharmacol. 344, 564-567.
36. Tsuei, S.E., Moore, R.E., Ashley, J.J., McBride, W.G., 1979. Disposition of synthetic glucocorticoids: 1. Pharmacokinetics of dexamethasone in healthy adults. J. Pharmacol. Biopharm. 7, 249-264.
37. Yamamoto, T., Shimura, T., Sako, N., Azuma, S., Bai, W.Z., Wakisaka, S., 1992. C-fos expression in the rat brain after intraperitoneal injection of lithium chloride. NeuroReport 3, 1049-1052.
38. Yarker, Y.E., McTavish, D., 1994. Granisetron: an update of its therapeutic use in nausea and vomiting induced by anti-neoplastic drugs. Drugs 48, 761-793.